remimazolam and Carotid-Stenosis

remimazolam has been researched along with Carotid-Stenosis* in 1 studies

Trials

1 trial(s) available for remimazolam and Carotid-Stenosis

ArticleYear
Effect of remimazolam versus propofol for the induction of general anesthesia on cerebral blood flow and oxygen saturation in elderly patients undergoing carotid endarterectomy.
    BMC anesthesiology, 2023, 05-04, Volume: 23, Issue:1

    This study was conducted to investigate the effects and safety of remimazolam versus propofol on cerebral oxygen saturation and cerebral hemodynamics during the induction of general anesthesia in patients receiving carotid endarterectomy (CEA), so as to provide theoretical basis for better clinical application of remimazolam.. Forty-three patients (60-75 years old) with carotid artery stenosis (carotid artery stenosis greater than 70%) were randomly divided into the remimazolam group (R group) and the propofol group (P group). Anesthesia was induced with remimazolam (0.3 mg/kg) or propofol (1.5-2 mg/kg) individually. At time of admission (T0), post-anesthesia induction (T1), consciousness disappears (T2), 1 min after loss of consciousness (T3), 2 min after loss of consciousness (T4) and pre-endotracheal intubation (T5), measurement in patients with regional cerebral oxygen saturation (SrO. SrO. Our study revealed that remimazolam can be administered safely and effectively during the induction of general anesthesia for carotid endarterectomy in elder population and it demonstrated superiority in hemodynamic changes compared with propofol.. This trial was retrospectively registered with the Chinese Clinical Trial Registry.. ChiCTR2300070370. Date of registration: April 11, 2023.

    Topics: Aged; Anesthesia, General; Carotid Stenosis; Cerebrovascular Circulation; Endarterectomy, Carotid; Humans; Middle Aged; Oxygen Saturation; Propofol; Unconsciousness

2023